# Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism

Study · id `cardio:ct-nct05821426` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05821426](<https://clinicaltrials.gov/study/NCT05821426>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05821426

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 130 participants.

## Technical summary

Registry record NCT05821426. Allocation not applicable; no masking; primary purpose treatment. Start 2026-07 (anticipated); primary completion 2027-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT05821426, source copy `cardio:ctgov-nct05821426-2025-09-29`, retrieved 2026-10-31)
- Planned start: 2026-07 (anticipated) (ClinicalTrials.gov record NCT05821426, source copy `cardio:ctgov-nct05821426-2025-09-29`, retrieved 2026-10-31)
- Primary completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT05821426, source copy `cardio:ctgov-nct05821426-2025-09-29`, retrieved 2026-10-31)
- Completion: 2027-10 (anticipated) (ClinicalTrials.gov record NCT05821426, source copy `cardio:ctgov-nct05821426-2025-09-29`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05821426-2025-09-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of the Magneto eTrieve™ PE Kit for Endovascular Thrombectomy in Subjects With Acute Pulmonary Embolism
- Acronym: eTrieve II
- Condition: Pulmonary Embolism
- Intervention (Device): eTrieve PE Kit
- Lead sponsor: Magneto Thrombectomy Solutions
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)

## Provenance

Content hash: eeac8bb5cfcf9c5a27ddc55f16291c279c8e249e76bfcc8465445e88dd6a92df
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
